Mark Sullivan is General Counsel & Secretary of Sesen Bio, Inc.. Currently has a direct ownership of 378,651 shares of SESN, which is worth approximately $238,550. The most recent transaction as insider was on Mar 02, 2023, when has been sold 219,218 shares (Common Stock) at a price of $0.59 per share, resulting in proceeds of $129,338. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 379K
0% 3M change
0% 12M change
Total Value Held $238,550

Mark Sullivan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Open market or private sale
$129,338 $0.59 p/Share
219,218 Reduced 36.67%
378,651 Common Stock
Mar 02 2023
BUY
Exercise of conversion of derivative security
$175,923 $0.59 p/Share
298,175 Added 41.32%
423,530 Common Stock
Feb 21 2023
SELL
Open market or private sale
$23,500 $0.59 p/Share
39,831 Reduced 11.73%
299,694 Common Stock
Feb 18 2022
BUY
Grant, award, or other acquisition
-
339,525 Added 50.0%
339,525 Common Stock

Also insider at

MNMD
Mind Medicine (MindMed) Inc. Healthcare
MS

Mark Sullivan

General Counsel & Secretary
Cambridge, MA

Track Institutional and Insider Activities on SESN

Follow Sesen Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SESN shares.

Notify only if

Insider Trading

Get notified when an Sesen Bio, Inc. insider buys or sells SESN shares.

Notify only if

News

Receive news related to Sesen Bio, Inc.

Track Activities on SESN